The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts.

The Ets variant gene 6 (ETV6/TEL) gene is rearranged in the majority of patients with 12p13 translocations fused to a number of different partners. We present here a case of acute myeloid leukemia M4 with eosinophilia (AML-M4Eo) positive for the CBFb/MYH11 rearrangement and carrying a t(1;12)(q25;p13) that involves the ETV6 gene at 12p13. By 3'rapid amplification of cDNA ends-polymerase chain reaction (3'RACE-PCR), a novel fusion transcript was identified between the ETV6 and the Abelson-related gene (ARG) at 1q25, resulting in a chimeric protein consisting of the HLH oligomerization domain of ETV6 and the SH2, SH3, and protein tyrosine kinase (PTK) domains of ARG. The reciprocal transcript ARG-ETV6 was also detected in the patient RNA by reverse transcriptase-polymerase chain reaction (RT-PCR), although at a lower expression level. The ARG gene encodes for a nonreceptor tyrosine kinase characterized by high homology with c-Abl in the TK, SH2, and SH3 domains. This is the first report on ARG involvement in a human malignancy.

[1]  C. Pui,et al.  The role of TEL fusion genes in pediatric leukemias , 1999, Leukemia.

[2]  F. Mitelman,et al.  Catalog of Chromosome Aberrations in Cancer , 1996, British Journal of Cancer.

[3]  J. Downing,et al.  12 p Abnormalities and the TEL Gene ( ETV 6 ) in Childhood Acute Lymphoblastic Leukemia , 1997 .

[4]  P. Marynen,et al.  Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. , 1997, Blood.

[5]  L. Wiedemann,et al.  Haemopoietic transformation by the TEL/ABL oncogene , 1998, British journal of haematology.

[6]  T. Golub,et al.  p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines. , 1996, Oncogene.

[7]  Todd R. Golub,et al.  Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation , 1994, Cell.

[8]  L. Kearney,et al.  Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies , 1998, Genes, chromosomes & cancer.

[9]  P. Marynen,et al.  Genomic organization of TEL: the human ETS-variant gene 6. , 1996, Genome research.

[10]  T. Golub,et al.  The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[11]  E. Macintyre,et al.  Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease , 1999, Leukemia.

[12]  P. Sorensen,et al.  A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma , 1998, Nature Genetics.

[13]  G. Kruh,et al.  Subcellular localization of the Arg protein tyrosine kinase. , 1996, Oncogene.

[14]  J. Downing,et al.  12p Abnormalities and the TEL Gene (ETV6) in Childhood Acute Lymphoblastic Leukemia , 1997 .

[15]  C. Sawyers.  Chronic myeloid leukemia. , 1999, The New England journal of medicine.

[16]  R Berger,et al.  A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. , 1997, Science.

[17]  S. Langabeer,et al.  Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials , 1997 .

[18]  M. Kraus,et al.  A novel human gene closely related to the abl proto-oncogene. , 1986, Science.

[19]  K. Tanaka,et al.  Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). , 1999, Blood.

[20]  D. Harnden,et al.  Catalog of Chromosome Aberrations in Cancer , 1989 .

[21]  S. Langabeer,et al.  Frequency of CBF beta/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials. The MRC Adult Leukaemia Working Party. , 1997, British journal of haematology.

[22]  L. Wiedemann,et al.  The novel activation of ABL by fusion to an ets-related gene, TEL. , 1995, Cancer research.

[23]  G. Kruh,et al.  Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain. , 1996, Oncogene.

[24]  T. Golub,et al.  Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia , 1996, Molecular and cellular biology.

[25]  M. Höglund,et al.  BCR/ABL‐negative chronic myeloid leukemia with ETV6/ABL fusion , 1997, Genes, chromosomes & cancer.

[26]  S. Aaronson,et al.  The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.